Tower Mains

✨ First-class training courses to meet your needs ✨   We love hearing feedback from our training courses and recently, we’ve had some fantastic testimonials from attendees who have appreciated our depth of content, practical insights, and hands-on approach.    Every bit of feedback is important to us, as it drives us to continuously improve our training experience and deliver even greater value!   If you'd like to discuss your specific training needs or wish to book for your group or organisation, please don’t hesitate to contact training@towermains.com.   #regulatorylandscape #training #careerdevelopment #QA #quality #towermains

Check out our latest newsletter! This week’s issue includes: 🔸 A consultation from the EMA on handling competing interests of scientific committee members and experts. 🔸 An upcoming Informed Consent webinar hosted by the FDA. 🔸 The launch of a high-concentration formulation platform to accelerate high-dose drug development. To read more, click here: https://lnkd.in/eeHD4N2h Stay up to date with the latest industry insights and regulatory news! If you’d like to receive our newsletters directly in your inbox, just email info@towermains.com with the subject line “Weekly Newsletter Please.” #pharma #biotech #regulatoryupdates #newsletter #EMA #FDA

We are delighted to share that our Founding Directors, Andrew Waddell and Fiona Waddell were invited to give special lectures to the Japan Society of Quality Assurance #JSQA earlier this month. Fiona provided an insightful presentation on the implementation progress of ICH E6(R3) across the UK and Europe, while Andrew reflected on lessons from his 45-year career in QA and the challenges faced, including the evolution of Artificial Intelligence and “Quality 4.0.” Both sessions were warmly received, sparking engaging discussions and interesting questions. There will be up to fourteen members of JSQA present at the upcoming #RQA meeting in Brighton next month, and while we will not be able to reproduce the warm Tokyo weather that Andrew and Fiona enjoyed, the warmth of their welcome should compensate. #qualityassurance #qaindustry #AI #rqa #jsqa #ICH #quality

Don't miss out on our newsletter for the latest industry and regulatory updates! This week's issue includes... 🔹 EMA's public consultation on the European Medicines Agencies Network Strategy (EMANS) to 2028 🔹 FDA's Center for Devices and Radiological Health (CDRH) expanding TAP pilot eligibility for breakthrough devices 🔹 The release of the ICH 2024 Implementation Survey report To read, click here: https://lnkd.in/eu6ZbRKg Stay informed! To receive our newsletters directly in your inbox, simply email info@towermains.com with the subject “Weekly Newsletter Please.”

Our weekly newsletter is here! This week’s issue includes: 🔸 A new initiative aimed at streamlining the assessment and approval process for new medicines in the EU. 🔸 WHO’s collaboration with TikTok to promote science-based information and combat misinformation. 🔸 The FDA’s announcement of $17.2 million in grants for rare disease clinical trials. https://lnkd.in/eYY2vS72 Stay informed with the latest industry news and regulatory updates! To receive our newsletters directly in your inbox, simply email info@towermains.com with the subject line “Weekly Newsletter Please.”

Don't miss our newsletter for the latest industry news and regulatory updates. This week's issue includes the call for applications for the MHRA AI Airlock pilot, a £2.7 million trial focused on improving gallstone treatment and the announcement of the first cohort of awardees for the £3 million Collaborative Drug Discovery Programme by the CF AMR Syndicate. https://lnkd.in/eAM45JEs To receive our newsletters directly to your inbox, send an email to info@towermains.com with the subject “Weekly Newsletter Please”

📢 Today, we’re at the BioCap 2024 Conference in Manchester's King's House Conference Centre, hosted by Bionow. Here’s how you can find us! Come and chat about how we can support you. Our Head of QA, Shona Ross, and Head of Operations, Lianne Roeling, will be there to say hello 👋 www.towermains.com #BioCap #lifesciences #healthcare #investment #biotech #qualityassurance

Today, our Senior Associate, Anna Lothian, is attending the Health Sciences Records & Archives Association (The HSRAA) Conference in Edinburgh. Offering an opportunity to learn from experts about the key challenges and trends in records management and archiving within the health sciences, the conference will cover topics including GxP migration, AI, digital records, the impact of the EU CTR, and the future of records management. We’re looking forward to hearing Anna’s takeaways from the event! www.towermains.com #HSRAA24 #GxP #documentmanagement #archiving #EUCTR #AI

📢 Our weekly newsletter is ready 📢 This issue includes the MHRA's newly launched strategy aimed at improving patient safety communications, details about the FDA's inaugural meeting of the Digital Health Advisory Committee set for November, and the latest regulatory updates. https://lnkd.in/e2ufSmAU To receive our newsletters directly to your inbox, send an email to info@towermains.com with the subject “Weekly Newsletter Please” #medicaldevices #regulatory #QA #clinicalresearch #GMP #compliance

Check out our newsletter for the latest news, developments, and regulatory updates. This week's issue includes new EU guidelines for large language models (LLMs) in medicine regulation, clarified terminology in the MHRA's statutory fee consultation, CurifyLabs' collaboration to aid critically ill patients with 3D printing medicine technology, and the latest industry news. https://lnkd.in/e_Fa8ztg To receive our newsletters directly to your inbox, send an email to info@towermains.com with the subject “Weekly Newsletter Please” #qualityassurance #industrynews #compliance #regulatory #clinicaltrials